Real-Time Detection of Ferulic Acid Effects on Rat Left Ventricle Using Pressure-Volume Conductivity Catheter
January 12th, 2024
This protocol describes a method for measuring left ventricular pressure and volume using the pressure-volume conductance technique. This method enables continuous real-time monitoring of the effects of drugs on the heart.
Anesthesia is an unavoidable issue in animal experiments. In this experiment, the different levels of anesthesia have a significant impact on the experimental results. This pressure-volume loop measurement method is easier to learn compared to the open-chest method, including fewer experimental tools and less learning time for experimenters.
Our lab will research traditional Chinese medicine's effects and mechanisms on cardiovascular diseases, exploring its extensive but not fully understood impact on heart health. To begin, immerse the pressure-volume sensor of the conduction catheter instrument into 0.9%sodium chloride solution. Once the sensor has been saturated, connect the experimental setup.
Press the Start icon on the software to automatically record the monitoring data from the pressure-volume sensor. Next, calibrate the pressure and conductivity with the Mikro-Tip pressure-volume software. Immobilize the anesthetized rats on an isothermal heating plate, keeping the back in contact with the plate.
Coat a temperature probe with petroleum jelly and insert the probe into the rectum of the rat. Now, make a four-centimeter long incision on the right side of the median line on the rat's neck. Use forceps to separate the muscle and connective tissue.
Isolate the carotid artery from the other tissues. Then place three 5-0 surgical lines below the carotid artery. Drip sterile 0.9%sodium chloride solution onto the artery to keep it moist.
Now, cut the skin above the left clavicle and peel off the tissue around the jugular vein. Cross the left jugular vein with a 5-0 surgical line. Then ligate the distal end of the right carotid artery.
Clamp the arterial clips proximally to suspend the blood flow. With micro scissors, cut a section in the vessel where the blood flow has stopped. Insert a catheter along the carotid artery deep into the left ventricle.
Ensure that the lowest systolic pressure after ventricle entry is close to zero millimeters of mercury. Slightly adjust the pressure-volume catheter to obtain a reasonable pressure-volume relationship. Ligate the proximal end of the surgical line to prevent massive blood loss and change in catheter position.
When the pressure-volume stabilizes, ligate the surgical line distal to the ligated jugular vein. Slowly inject up to one milliliter per kilogram of ferulic acid. Now, inject 50 microliters of 20%sodium chloride solution from the left jugular vein to remove the parallel conductance generated by the myocardium.
Once the testing is complete, use a blood collection needle to withdraw blood from the rat's abdominal aorta. Transfer the collected blood into a sodium heparin collection tube and invert the tube two times to prevent blood clotting. After euthanizing the animal with excess anesthesia, place the collected blood into the orifice of a calibration tube.
The catheter will automatically detect the blood conductance and record it in the monitoring module. A marked increase in pressure was observed as the catheter entered the left ventricle from the carotid artery. The left ventricular pressure was observed to be within 10 to 105 millimeters of mercury, and the conductance volumes were within 65 to 115 microliters.
The complete cardiac cycle was formed by the counterclockwise pressure-volume loop. The administration of ferulic acid induced significant changes in the heart function. The injection of hypertonic saline through the left jugular vein caused an increase in conductivity values.
Overview
This protocol describes a method for measuring left ventricular pressure and volume using the pressure-volume conductance technique. This method enables continuous real-time monitoring of the effects of drugs on the heart.
Key Study Components
Area of Science
- Cardiovascular physiology
- Pharmacology
- Experimental methodology
Background
- Anesthesia significantly impacts experimental results in animal studies.
- The pressure-volume loop measurement method is easier to learn than the open-chest method.
- This method requires fewer experimental tools and less learning time.
- Research focuses on traditional Chinese medicine's effects on cardiovascular diseases.
Purpose of Study
- To explore the effects and mechanisms of traditional Chinese medicine on heart health.
- To improve methods for measuring cardiac function.
- To enhance understanding of drug effects on the heart.
Methods Used
- Pressure-volume conductance technique for real-time monitoring.
- Use of a pressure-volume sensor immersed in saline solution.
- Connection of the sensor to an experimental setup for data collection.
- Comparison of results with traditional measurement methods.
Main Results
- Real-time monitoring provides immediate feedback on cardiac function.
- The method shows promise for evaluating drug effects on the heart.
- Findings may lead to better understanding of cardiovascular health.
- Traditional Chinese medicine may have significant impacts on heart health.
Conclusions
- The pressure-volume conductance technique is effective for cardiac studies.
- It simplifies the learning process for researchers.
- Further research is needed to fully understand the effects of traditional Chinese medicine.
Frequently Asked Questions
Executive Industry Relevance
Real-time pressure-volume loop analysis in rat models enables direct, quantitative assessment of cardiac function under pharmacological intervention. This approach provides high-resolution data critical for early-stage cardiovascular drug evaluation and mechanistic de-risking. Integrating such measurements strengthens predictive confidence at the discovery-to-preclinical inflection point for cardiac therapeutics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of cardiac functional hypotheses in vivo.
- Supports mechanistic de-risking by quantifying drug-induced changes in ventricular performance.
- Facilitates functional target validation for cardiovascular drug candidates.
Screening & Assay Development
- Provides validated, quantitative pressure-volume outputs for assay standardization.
- Enables reproducible, real-time monitoring of cardiac response to compounds.
- Supports development of scalable in vivo screening platforms for cardiac function.
Translational & Preclinical Research
- Aligns preclinical cardiac function data with disease-relevant endpoints.
- Enables continuity from early discovery through preclinical efficacy assessment.
- Supports risk-adjusted advancement decisions for cardiovascular portfolios.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical validation by providing real-time, quantitative cardiac function data in response to drug administration.
- Discovery Biology: Supports hypothesis testing and mechanistic clarification of cardiac drug effects.
- Screening: Delivers reproducible, quantitative pressure-volume loop data for compound evaluation.
- Analytics: Enables statistical comparison of cardiac function across treatment conditions.
- Translational Research: Provides endpoints relevant to preclinical and translational cardiac studies.
- Enterprise Reuse: Establishes a reusable platform for cardiac function assessment across drug programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cardiac drug evaluation.
- Operational Value: Standardizes in vivo cardiac assessment with reproducible, quantitative outputs.
- Strategic Value: Improves go/no-go decisions and capital allocation for cardiovascular assets.
- Portfolio Impact: Enables risk-adjusted prioritization of cardiac drug candidates.
Implementation Considerations
- Requires expertise in small animal surgery and cardiovascular physiology.
- Demands specialized pressure-volume catheter instrumentation and analytical software.
- Necessitates rigorous cross-team standardization of anesthesia and procedural variables.
- Adaptation may be needed for different animal models or cardiac disease states.
- Careful control of confounding variables, such as anesthesia depth, is essential for data integrity.
